Clinical Trial Update: Study of AG-120 and AG-881 in Subjects With Low Grade Glioma [Phase 1]

View source ↗

Summary

The study reports the completion of a Phase 1 trial evaluating AG-120 (ivosidenib) and AG-881 (vorasidenib) in subjects with low-grade glioma. The sponsor is In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• AG-120 (ivosidenib)
• AG-881 (vorasidenib)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Glioma | Phase 1 | Status: COMPLETED